Stock ownership · SEC 13F · Q3 2025

INVESCO PHARMACEUTICALS ETF

A breakdown of INVESCO PHARMACEUTICALS ETF's institutional base (CUSIP 46137V662): the holders, the concentration among them, and what changed last quarter.

$796K
Reported value
4
Institutions
100%
Top-5 share

The verdict

$796K of INVESCO PHARMACEUTICALS ETF is reported by 4 institutions as of Q3 2025; ownership is held overwhelmingly by a small core of institutions.

4
institutions hold it
$796K
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 46137V662 · Q3 2025 $1M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-MID · BOOK-MID

  • VALUE-TRACE $0.8M
  • HOLDERS-FOCUS 4 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-MID 4 new
  • BOOK-MID 4Q history

Read with: Ownership concentration guide - INVESCO PHARMACEUTICALS ETF's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of INVESCO PHARMACEUTICALS ETF
  1. 1
    WBI INVESTMENTS, LLC $499K
  2. 2
    CIBC Private Wealth Group LLC $203K
  3. 3
    JPMORGAN CHASE & CO $93K
  4. 4
    Asset Dedication, LLC $1K

Top 4 reported holders by value · Q3 2025

Institutional ownership over time

The number of institutions reporting a INVESCO PHARMACEUTICALS ETF position has risen from 1 to 4 over the last 4 quarters of 13F filings.

012345 Q1'24Q4'24Q1'25Q3'25 4
Distinct 13F filers holding INVESCO PHARMACEUTICALS ETF, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 WBI INVESTMENTS, LLC 5,395 $499K 62.6%
2 CIBC Private Wealth Group LLC 2,200 $203K 25.5%
3 JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) 1,004 $93K 11.7%
4 Asset Dedication, LLC 13 $1K 0.2%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among INVESCO PHARMACEUTICALS ETF's reported holders for Q3 2025, by reported value:

Sole discretion (SOLE)
88.3%
Shared-defined discretion (DFND)
11.7%

Latest Quarter Activity · Q3 2025

New positions (4)

WBI INVESTMENTS, LLC $499K
CIBC Private Wealth Group LLC $203K
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) $93K
Asset Dedication, LLC $1K

Frequently Asked Questions

How many institutions hold INVESCO PHARMACEUTICALS ETF?▼
INVESCO PHARMACEUTICALS ETF is held by 4 institutional investors per the latest SEC Form 13F filings as of Q3 2025.
What is the total institutional value of INVESCO PHARMACEUTICALS ETF?▼
Institutions report $796K of INVESCO PHARMACEUTICALS ETF as of Q3 2025.
How concentrated is ownership of INVESCO PHARMACEUTICALS ETF?▼
The top five institutional holders account for 100% of the reported institutional value in INVESCO PHARMACEUTICALS ETF, making ownership held overwhelmingly by a small core of institutions.
Who is the largest institutional holder of INVESCO PHARMACEUTICALS ETF?▼
WBI INVESTMENTS, LLC is the largest reported holder of INVESCO PHARMACEUTICALS ETF with $499K across 5,395 shares as of Q3 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.